An Act relative to provider choice
Take action
Record your position on this measure.
Create an account to take a stance, submit a written position, or contact your legislator.
Progress
Where this bill stands in the legislative process.
- Introduced
- Passed House
- Passed Senate
- To Governor
- Became Law
Overview
This bill establishes a Vaccine Program Advisory Council to advise the Department of Public Health on vaccine funding and implementation. It also creates a surcharge for vaccine purchasers to fund vaccine purchases and administration, with a limit on annual increases. Finally, the bill mandates that healthcare providers participating in state immunization programs can choose the vaccine brand they administer, subject to certain limitations and considerations for patient and provider confidence.
Key provisions
- Creates a Vaccine Program Advisory Council with diverse representation.
- Establishes a routine childhood immunizations surcharge to fund vaccine purchases.
- Limits the annual increase in the surcharge to the health care cost growth benchmark.
- Requires healthcare providers to be able to choose vaccine brands, subject to FDA and CDC recommendations.
- Allows the Department of Public Health to exclude certain brands based on safety or cost.
- Sets a deadline of July 1, 2026, for full implementation of the brand choice requirement.
- Extends the provider immunization brand choice requirement to other immunization programs.
- Specifies exceptions to the brand choice requirement during shortages or emergencies.
Who is affected
- Healthcare providers
- Vaccine purchasers
- Patients
- The Department of Public Health
- Managed care organizations
Bill text
Read the latest version inline or switch to a previous version.
Text extraction is in progress. View the official source.
Sponsors
Official sponsors from legislative records.
1 on record
Primary sponsor
Joint Committee on Health Care Financing
Arguments
Reasons offered for and against this legislation.
Arguments in favor
No arguments in favor have been submitted.
Submit yoursArguments opposed
No arguments opposed have been submitted.
Submit yours